ALPHA COGNITION INC.
Profile
Company Names
ALPHA COGNITION INC.
NEURODYN COGNITION INC.
Addresses
1200 - 750 WEST PENDER STREET, VANCOUVER, A1 V6C 2T8
20073 FIDDLER-S GREEN, FRISCO, TX 75036
301 - 1228 HAMILTON STREET, VANCOUVER, A1 V6B 6L2
439 HELMCKEN STREET, VANCOUVER, A1 V6B 2E6
Phone Numbers
(858) 344-4375
(604) 564-9244
(604) 684-3323
Entity Type:
CORPORATION
Industry:
BIOTECHNOLOGY
Year Incorporated:
2014
State Incorporated:
BRITISH COLUMBIA, CANADA
Total Amount Raised:
$27,879,211.00
Number of Funding Rounds:
17
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
17
2024-10-21
$0.00
$346,944.00
$346,944.00
16
2024-09-24
$4,545,000.00
$11,143,857.00
$6,598,857.00
Equity, Debt
15
2024-01-24
$2,839,628.00
$6,840,921.00
$4,001,293.00
Equity
14
2023-12-22
$1,762,097.00
$4,245,053.00
$2,482,956.00
Equity
13
2023-11-08
$1,009,999.00
$1,721,588.00
$711,589.00
Equity
12
2023-10-16
$343,999.00
$586,361.00
$242,362.00
Equity
11
2023-08-31
$1,260,837.00
$2,149,152.00
$888,315.00
Equity
10
2023-03-15
$1,286,748.00
$3,254,716.00
$1,967,968.00
Equity
9
2023-02-16
$1,847,827.00
$4,673,916.00
$2,826,089.00
Equity
8
2021-10-01
$424,983.00
$920,796.00
$495,813.00
Equity
7
2020-12-18
$1,457,000.00
$1,457,000.00
$0.00
6
2020-04-27
$1,915,000.00
$1,915,000.00
$0.00
Debt
5
2019-08-30
$5,951,093.00
$5,951,093.00
$0.00
Equity
4
2018-07-05
$2,000,000.00
$4,000,000.00
$2,000,000.00
Debt
3
2017-02-28
$200,000.00
$200,000.00
$0.00
Equity
2
2016-04-04
$385,000.00
$385,000.00
$0.00
Equity
1
2015-09-30
$650,000.00
$650,000.00
$0.00
Equity
People
First Name
Middle Name
Last Name
Titles
Related Companies
KENNETH
CAWKELL
DIRECTOR, EXECUTIVE OFFICER
KENNETH
A.
CAWKELL
EXECUTIVE OFFICER, DIRECTOR
RICHARD
DEVRIES
DIRECTOR
ANTHONY
GIOVINAZZO
DIRECTOR
DENIS
G.
KAY
EXECUTIVE OFFICER, DIRECTOR
MICHAEL
MCFADDEN
EXECUTIVE OFFICER, DIRECTOR
JAMES
MERTZ
DIRECTOR
LEN
MERTZ
DIRECTOR
ERICH
MOHR
DIRECTOR
FREDERICK
SANCILIO
DIRECTOR, EXECUTIVE OFFICER
JEREMY
WRIGHT
EXECUTIVE OFFICER
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
BIOTECHNOLOGY
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
DECLINE TO DISCLOSE
2024-10-21
D
BIOTECHNOLOGY
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
DECLINE TO DISCLOSE
Equity, Debt
2024-09-24

